Novartis Drug Heralds Multiple Sclerosis Advances (Update2) - Bloomberg

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service71 times read : Adjust font size: Decrease font Enlarge font
image

April 27 (Bloomberg) -- The first in a new wave of multiple sclerosis medicines, from drugmakers led by Novartis AG and Merck KGaA , may reach the market next year, making therapy more convenient for patients and boosting profits. In Seattle this ...

Read this article...



Post your comment comment Comments (0 posted)

More News

copyright